Product Images Regranex
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Regranex NDC 50484-810 by Smith & Nephew, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
c080f728-figure-01 - c080f728 figure 01
c080f728-figure-02 - c080f728 figure 02
REGRANEX® Syl (becaplermin) is a gel used in the treatment of diabetic foot ulcers. It contains 0.01% becaplermin and other inactive ingredients like carbaymethylcellulose sodium, glacial acetic acid, lysine hydrochloride, m-cresol, methylparaben, propylparaben, sodium acetate trihydrate, sodium chloride, and water for injection. The product should be refrigerated between 2-8°C (36-46°F) and should not be frozen. The lot number and expiration date can be found on the seal. If the seal is missing or damaged, the product should not be used. The product comes with a package insert that contains dosage and administration details. Keep the product out of reach of children.*
c080f728-figure-03 - c080f728 figure 03
REGRANEX is a topical gel medication for prescription use only. Its active ingredient is becaplermin 0.01%, with carbormethyiceliiose. The medication is dispensed in a multi-dose tube, and should not be used if the seal has been punctured or is not visible. The cap should be used to puncture the seal when opening the medication, and the cap should be securely replaced after each use. Manufactured by Smith & Nephew, Inc., REGRANEX is a registered trademark. See the end of the tube for the lot number and expiration date.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.